Published in J Clin Endocrinol Metab on June 01, 1998
Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry (2015) 1.89
Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res (2010) 1.65
Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001. Pain Med (2010) 1.43
Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacol Biochem Behav (2006) 1.31
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res (2009) 1.27
Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2010) 1.27
Hormonal, cardiovascular, and subjective responses to acute stress in smokers. Psychopharmacology (Berl) (2008) 1.19
Neurosteroids, GABAA receptors, and ethanol dependence. Psychopharmacology (Berl) (2005) 1.18
The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research. Neurosci Biobehav Rev (2010) 1.16
Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues Clin Neurosci (2006) 1.15
Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry (2009) 1.14
Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alcohol Res (2012) 1.10
Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum. Steroids (2009) 1.10
Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology (2007) 1.08
Estrogen action: a historic perspective on the implications of considering alternative approaches. Physiol Behav (2009) 1.07
Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology (Berl) (2003) 1.05
Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther (2007) 1.05
Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl) (2005) 1.05
Differential effects of ethanol on serum GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in mice, rats, cynomolgus monkeys, and humans. Alcohol Clin Exp Res (2009) 1.04
Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology (Berl) (2006) 1.03
Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors. Horm Behav (2009) 1.01
Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc Natl Acad Sci U S A (2004) 1.01
Cardiovascular, hormonal, and emotional responses to the TSST in relation to sex and menstrual cycle phase. Psychophysiology (2010) 1.01
Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) (2005) 0.95
Neuroactive steroid stereospecificity of ethanol-like discriminative stimulus effects in monkeys. J Pharmacol Exp Ther (2008) 0.95
Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp Neurol (2005) 0.94
Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol. Psychopharmacology (Berl) (2005) 0.94
Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology (2009) 0.94
Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl) (2014) 0.92
Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis. J Pharmacol Exp Ther (2013) 0.92
Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res (2015) 0.90
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. Front Cell Neurosci (2014) 0.90
Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent. Curr Alzheimer Res (2007) 0.89
Time-dependent modulation of GABA(A)-ergic synaptic transmission by allopregnanolone in locus coeruleus neurons of Mecp2-null mice. Am J Physiol Cell Physiol (2013) 0.89
Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women. Psychopharmacology (Berl) (2005) 0.89
Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) (2006) 0.89
Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans? Psychopharmacology (Berl) (2014) 0.89
Myelin pathogenesis and functional deficits following SCI are age-associated. Exp Neurol (2008) 0.87
Neurosteroid influences on sensitivity to ethanol. Front Endocrinol (Lausanne) (2012) 0.87
Uncovering steroidopathy in women with autism: a latent class analysis. Mol Autism (2014) 0.87
Differential hypothalamic-pituitary-adrenal activation of the neuroactive steroids pregnenolone sulfate and deoxycorticosterone in healthy controls and alcohol-dependent subjects. Psychoneuroendocrinology (2007) 0.86
A sensitive and selective LC-differential mobility-mass spectrometric analysis of allopregnanolone and pregnanolone in human plasma. Anal Bioanal Chem (2013) 0.85
Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor. Front Neurosci (2012) 0.85
Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease. Front Endocrinol (Lausanne) (2012) 0.84
The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders. Psychopharmacology (Berl) (2014) 0.84
Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion. Front Endocrinol (Lausanne) (2011) 0.84
Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology (Berl) (2005) 0.83
Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone. Cell Calcium (2011) 0.83
The impact of sex hormone concentrations on decision-making in females and males. Front Neurosci (2014) 0.82
Neurosteroids and GABA-A Receptor Function. Front Endocrinol (Lausanne) (2011) 0.82
Nociceptive and anxiety-like behavior in reproductively competent and reproductively senescent middle-aged rats. Gend Med (2009) 0.81
Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease. Age (Dordr) (2009) 0.80
Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies. Psychopharmacology (Berl) (2014) 0.80
Progesterone facilitates exploration, affective and social behaviors among wildtype, but not 5α-reductase Type 1 mutant, mice. Behav Brain Res (2013) 0.80
Stress, rejection, and hormones: Cortisol and progesterone reactivity to laboratory speech and rejection tasks in women and men. F1000Res (2014) 0.78
Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. Arch Womens Ment Health (2009) 0.78
Menstrual phase, depressive symptoms, and allopregnanolone during short-term smoking cessation. Exp Clin Psychopharmacol (2013) 0.78
Allopregnanolone in the bed nucleus of the stria terminalis modulates contextual fear in rats. Front Behav Neurosci (2015) 0.77
Not all depression is created equal: sex interacts with disease to precipitate depression. Biol Sex Differ (2013) 0.77
Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology (Berl) (2014) 0.77
Allopregnanolone assays. J Clin Endocrinol Metab (2001) 0.77
Reduction of circulating and selective limbic brain levels of (3α,5α)-3-hydroxy-pregnan-20-one (3α,5α-THP) following forced swim stress in C57BL/6J mice. Psychopharmacology (Berl) (2014) 0.76
DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action. Psychopharmacology (Berl) (2015) 0.76
Hemodynamic and psychological responses to laboratory stressors in women: assessing the roles of menstrual cycle phase, premenstrual symptomatology, and sleep characteristics. Int J Psychophysiol (2012) 0.76
GABA Signaling and Neuroactive Steroids in Adrenal Medullary Chromaffin Cells. Front Cell Neurosci (2016) 0.76
Allopregnanolone preferentially induces energy-rich food intake in male Wistar rats. Physiol Rep (2014) 0.75
Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women. Behav Pharmacol (2011) 0.75
Stress-induced increases in progesterone and cortisol in naturally cycling women. Neurobiol Stress (2016) 0.75
Synthetic neurosteroids on brain protection. Neural Regen Res (2015) 0.75
Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder. Psychopharmacology (Berl) (2014) 0.75
Changes in stress-stimulated allopregnanolone levels induced by neonatal estradiol treatment are associated with enhanced dopamine release in adult female rats: reversal by progesterone administration. Psychopharmacology (Berl) (2016) 0.75
Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females. Psychopharmacology (Berl) (2004) 0.75
Juvenile social isolation affects maternal care in rats: involvement of allopregnanolone. Psychopharmacology (Berl) (2017) 0.75
Human-mouse genome comparisons to locate regulatory sites. Nat Genet (2000) 8.08
Neuroactive steroids. FASEB J (1992) 3.41
Neurosteroids act on recombinant human GABAA receptors. Neuron (1990) 2.44
Understanding weight gain at menopause. Climacteric (2012) 2.22
Complete sequence of pSC101. Nucleic Acids Res (1984) 2.22
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet (1999) 2.05
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med (2000) 1.94
Computational evidence in favor of a two-state, two-mode model of the retinal chromophore photoisomerization. Proc Natl Acad Sci U S A (2000) 1.92
Potyvirus proteins: a wealth of functions. Virus Res (2001) 1.85
Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia (2004) 1.79
Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol (1998) 1.76
Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res (1999) 1.72
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58
Influence of age and sex on serum concentrations of total dimeric activin A. Eur J Endocrinol (1998) 1.54
Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost (1996) 1.51
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. Fertil Steril (1995) 1.47
Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab (1996) 1.46
Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem (2000) 1.45
Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Br J Obstet Gynaecol (1999) 1.40
Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia (2003) 1.39
Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation. Br J Haematol (1996) 1.39
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39
Migraine with aura and reproductive life events: a case control study. Cephalalgia (2000) 1.39
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? J Thromb Haemost (2005) 1.38
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer. Eur J Cancer (1993) 1.38
Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology (1996) 1.36
Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Haemost (1995) 1.36
Two TaqI RFLPs in the human von Willebrand factor gene. Nucleic Acids Res (1987) 1.33
Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol (1999) 1.32
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. J Med Chem (1996) 1.29
Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol (1990) 1.29
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest (1965) 1.28
Potyviral HC-Pro: a multifunctional protein. J Gen Virol (1996) 1.26
High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod (2003) 1.25
Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. Mol Pharmacol (1997) 1.24
Stress and neuroactive steroids. Int Rev Neurobiol (2001) 1.24
Complete sequence of an IS element present in pSC101. Nucleic Acids Res (1981) 1.22
PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res (1987) 1.22
Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception (1995) 1.22
Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand (1991) 1.18
The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res (1998) 1.18
Neonatal screening for congenital adrenal hyperplasia. Arch Dis Child (1983) 1.17
Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol (1985) 1.16
Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab (2000) 1.16
Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig (1993) 1.16
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. Epilepsia (1985) 1.14
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation (2000) 1.14
The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res (1999) 1.14
Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect (2004) 1.13
Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther (1996) 1.12
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol (1997) 1.12
Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology (1998) 1.11
Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol (2001) 1.10
Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab (1994) 1.10
Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Invest (2000) 1.10
Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature (1987) 1.10
Activin, inhibin and the human breast. Mol Cell Endocrinol (2004) 1.10
Quinolone binding to DNA is mediated by magnesium ions. Proc Natl Acad Sci U S A (1992) 1.10
Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol (2012) 1.09
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod (2007) 1.08
Preferential maternal derivation in inv dup(15): analysis of eight new cases. Hum Genet (1981) 1.08
Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone. J Pharmacol Exp Ther (2001) 1.07
Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem (2000) 1.07
Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons. Neurosci Lett (1992) 1.07
Growth charts, growth velocity and bone development in childhood obesity. Int J Obes Relat Metab Disord (1995) 1.06
Gene deletion in an Italian haemophilia B subject. J Med Genet (1985) 1.05
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol (2007) 1.05
Gene expression from viral RNA genomes. Plant Mol Biol (1996) 1.05
6-Aminoquinolones as new potential anti-HIV agents. J Med Chem (2000) 1.05
A heminested polymerase chain reaction for the detection of Brazilian rabies isolates from vampire bats and herbivores. Mem Inst Oswaldo Cruz (2002) 1.04
Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res (1997) 1.04
Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod (2006) 1.03
The effect of the minor groove binding agent DAPI (4,6-diamidino-2-phenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli [corrected]. FEMS Microbiol Lett (1990) 1.03
Ethanol-like discriminative stimulus effects of endogenous neuroactive steroids: effect of ethanol training dose and dosing procedure. J Pharmacol Exp Ther (1999) 1.03
Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies. J Pharmacol Exp Ther (1994) 1.03
The frequency of oligonucleotides in mammalian genic regions. Comput Appl Biosci (1989) 1.03
Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci (1995) 1.02
Fetal sex and preterm birth. Placenta (2012) 1.02
Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J Steroid Biochem (1989) 1.02
Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alpha-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). Psychopharmacology (Berl) (1997) 1.02
Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr Med Chem (2009) 1.02
Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur J Pharmacol (1993) 1.00
Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. Eur J Endocrinol (1998) 1.00
Ethanol-like discriminative stimulus effects of the neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in female Macaca fascicularis monkeys. Psychopharmacology (Berl) (1996) 1.00
Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol (1991) 1.00